FDAFDA · Food and drugs·Recall number D-0188-2024
Lisinopril and Hydrochlorothiazide Tablets USP, 10mg/12.5mg, Rx only, 100 Tablets per bottles, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Nagpur-441 108, India. NDC: 68180-518-01
Published January 3, 2024 · Recall initiated: January 26, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- LISINOPRIL AND HYDROCHLOROTHIAZIDE
- Manufacturer
- CARDINAL HEALTHCARE
- Distributor
- Nationwide USA
- UPC
- 0368180519010
- Lot
- Batch Q101699, Q101981
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.